The tweet was deleted by the author.
But we saved everything 🙂.
Definium Therapeutics announced it will hold its Investor and Analyst Day in New York City on April 22 from 10:00 AM to 12:00 PM ET.
The company plans to have its executive leadership team and leading external speakers present perspectives on the evolving treatment landscape. The event is set to take place in person, targeting investors and analysts interested in Definium Therapeutics' latest updates. Details are available via the company’s official channels.
Definium Therapeutics recently published its full-year 2025 financial results and business update. The company also offered a replay of its conference call reviewing the results. The upcoming Investor and Analyst Day follows these recent disclosures.